# Ameriserv Financial Inc: overview ASRV · Nasdaq · CIK 707605 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/asrv.md) · [Financials](/companies/asrv/financials.md) · [Filings](/companies/asrv/filings.md) · [Insiders](/companies/asrv/insiders.md) Latest reported revenue: [$3.9m](/filings/0001104659-26-096940.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-096940). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,879](/filings/0001104659-25-111219.md) | [3,810 d](/filings/0001104659-26-031270.md) | [3,470](/filings/0001104659-26-061052.md) | [3,601](/filings/0001104659-26-096940.md) | [3,660](/filings/0001104659-25-111219.md) | [3,903 d](/filings/0001104659-26-031270.md) | [3,611](/filings/0001104659-26-061052.md) | [3,871](/filings/0001104659-26-096940.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [30.5%](/filings/0001104659-26-031270.md) | [23.3% d](/filings/0001104659-26-031270.md) | [55.0%](/filings/0001104659-26-061052.md) | [(7.8%)](/filings/0001104659-26-096940.md) | [69.5%](/filings/0001104659-26-031270.md) | [36.9% d](/filings/0001104659-26-031270.md) | [49.7%](/filings/0001104659-26-061052.md) | [70.7%](/filings/0001104659-26-096940.md) | | Diluted EPS | $ per share | [0.07](/filings/0001104659-26-031270.md) | [0.05](/filings/0001104659-26-031270.md) | [0.12](/filings/0001104659-26-061052.md) | [(0.02)](/filings/0001104659-26-096940.md) | [0.15](/filings/0001104659-26-031270.md) | [0.09](/filings/0001104659-26-031270.md) | [0.11](/filings/0001104659-26-061052.md) | [0.16](/filings/0001104659-26-096940.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [15.0](/filings/0001558370-24-004100.md) | [14.7](/filings/0001558370-24-004100.md) | [14.5](/filings/0001558370-25-003291.md) | [15.6](/filings/0001104659-26-031270.md) | [14.6](/filings/0001104659-26-031270.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [47.2%](/filings/0001558370-24-004100.md) | [50.5%](/filings/0001558370-25-003291.md) | [(23.1%)](/filings/0001104659-26-031270.md) | [23.1%](/filings/0001104659-26-031270.md) | [38.3%](/filings/0001104659-26-031270.md) | | Diluted EPS | $ per share | [0.41](/filings/0001558370-24-004100.md) | [0.43](/filings/0001558370-24-004100.md) | [(0.20)](/filings/0001558370-25-003291.md) | [0.21](/filings/0001104659-26-031270.md) | [0.34](/filings/0001104659-26-031270.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/asrv/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [GENDELL JEFFREY L](/funds/1056581.md) | 2026-06-30 | $6.3m | 1,635,677 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $4.5m | 1,155,397 | | Added +1,697 | | [AmeriServ Wealth Advisors](/funds/1102062.md) | 2026-06-30 | $3.5m | 889,464 | | Added +374 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.6m | 660,581 | | Added +2,186 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.1m | 535,774 | | Reduced −28,700 | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $1.4m | 364,422 | | Added +11,839 | | [EWA, LLC](/funds/1835252.md) | 2026-06-30 | $960.3k | 247,487 | | Added +1,875 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $801.7k | 206,629 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $586.9k | 151,262 | | Added +11,007 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $552.5k | 142,339 | | Reduced −2,054 | ## Recent filings [All 1,327 filings](/companies/asrv/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 12:56 ET | [8-K](/filings/0001104659-26-117984.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117984 | | 2026-10-20 | 13:01 ET | [8-K](/filings/0001104659-26-117201.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117201 | | 2026-08-14 | 18:57 ET | [10-Q](/filings/0001104659-26-096940.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096940 | | 2026-07-24 | 20:30 ET | [8-K](/filings/0001104659-26-086662.md) | 5.07 Shareholder vote results | 0001104659-26-086662 | | 2026-07-23 | 20:46 ET | [8-K](/filings/0001104659-26-086301.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-086301 | | 2026-07-21 | 14:11 ET | [8-K](/filings/0001104659-26-085285.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-085285 | | 2026-06-08 | 10:26 ET | [DEF 14A](/filings/0001140361-26-024337.md) | Proxy statement, period 2026-07-23 | 0001140361-26-024337 | | 2026-05-27 | 13:00 ET | [8-K](/filings/0001104659-26-066629.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001104659-26-066629 | | 2026-05-14 | 19:02 ET | [10-Q](/filings/0001104659-26-061052.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061052 | | 2026-04-21 | 13:31 ET | [8-K](/filings/0001104659-26-045779.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-045779 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-031270.md), filed Mar 18, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 707605 - Tickers: ASRV - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: PA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.